MOTILSTOP

This brand name is authorized in Nigeria.

Active ingredients

The drug MOTILSTOP contains one active pharmaceutical ingredient (API):

1	Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE
	By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.
	Read more about Loperamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A11-0962	Capsule	Motilstop Capsule_ CAP 2 mg 10 x 10's (in Alu PVC blisters)	Hard Capsule. Hard gelatin capsules size 4 with a mauve opaque body and a dark green opaque cap. Marked “LOPERA-MIDE 2” on the cap. MOTILSTOP CAPSULE LOPERAMIDE A11-0962 CAPSULES ORAL LOPERAMIDE 20MG 10X10 POM EMZOR PHARMA. IND. LTD,FLOWERGATE MIXED DEVELOPMENT SCHEME.KM 1 SAGAMU/BENIN EXPRESSWAY,SAGAMU,OGUN-STATE EMZOR PHARMA. IND. LTD,FLOWERGATE MIXED DEVELOPMENT SCHEME.KM 1 SAGAMU/BENIN EXPRESSWAY,SAGAMU,OGUN-STATE NIGERIA 07/03/2020 2ND JULY, 2025	03/07/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A11-0962